Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Pharmacy|June 1, 1992
Bioequivalence of verapamil hydrochloride extended-release pellet-filled capsules when opened and sprinkled on food and when swallowed intactG D Kozloski, J M De Vito, J B Johnson, et al.
Pharmacotherapy|March 1, 1996
Multiple-dose, placebo-controlled, phase I study of oral dolasetronT L Hunt, M Cramer, J Christy-Bittel, et al.
Clinical Therapeutics|September 18, 2001
Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladderJ A Ricci, J S Baggish, T L Hunt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapyE A Calhoun, E E Welshman, C-H Chang, et al.
Biopharmaceutics & Drug Disposition|April 17, 2001
Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochlorideR D Toothaker, S H Barker, M V Gillen, et al.
Urology|May 30, 2001
Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based surveyJ N Liberman, T L Hunt, W F Stewart, et al.
World Journal of Urology|June 18, 2003
Prevalence and burden of overactive bladder in the United StatesW F Stewart, J B Van Rooyen, G W Cundiff, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
Effect of the acyl-CoA:cholesterol acyltransferase inhibitor DuP 128 on cholesterol absorption and serum cholesterol in humansJ W Hainer, J G Terry, J M Connell, et al.
American Journal of Therapeutics|March 31, 1999
Effect of montelukast on single-dose theophylline pharmacokineticsK Malmstrom, J Schwartz, T F Reiss, et al.
Clinical Pharmacology and Therapeutics|February 17, 2001
The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarinJ I Schwartz, K J Bugianesi, D L Ebel, et al.
Pageof 2